ADMA BIOLOGICS, INC. Quarterly Contract with Customer, Liability, Current in USD from Q4 2020 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary: Adma Biologics, Inc. quarterly Contract with Customer, Liability, Current history and growth rate from Q4 2020 to Q1 2025.
Adma Biologics, Inc. Contract with Customer, Liability, Current for the quarter ending March 31, 2025 was $143K, a 87.2% decline year-over-year.

Contract with Customer, Liability, Current, Quarterly (USD)

Contract with Customer, Liability, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$143K	-$975K	-87.2%	Mar 31, 2025	10-Q	2025-05-07
Q4 2024	$143K	-$39K	-21.4%	Dec 31, 2024	10-Q	2025-05-07
Q3 2024	$143K	+$166	+0.12%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$1.13M	+$987K	+691%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$1.12M	+$975K	+683%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$182K	+$39K	+27.3%	Dec 31, 2023	10-K	2025-03-18
Q3 2023	$143K	$0	0%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$143K	$0	0%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$143K	$0	0%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$143K	+$166	+0.12%	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$143K	$0	0%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$143K	$0	0%	Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$143K			Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$143K	$0	0%	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$143K			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$143K			Jun 30, 2021	10-Q	2021-08-11
Q4 2020	$143K			Dec 31, 2020	10-K	2022-03-24

Showing 1 to 17 of 17 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.